• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 16 No. 1 (2020): IJPS_Volume 16_Issue 1 (2020)
  4. Research/Original Articles

Vol. 16 No. 1 (2020)

January 2020

Formulation Development and Evaluation of Gastro Retentive Floating Drug Delivery System for Novel Fluoroquinolone using Natural and Semisynthetic Polymers Formulation development and evaluation of Moxifloxacin. HCl gastroretentive floating tablets

  • Raghavendra Kumar Gunda
  • A. Vijayalakshmi

Iranian Journal of Pharmaceutical Sciences, Vol. 16 No. 1 (2020), 15 January 2020 , Page 49-60
https://doi.org/10.22037/ijps.v16.40446

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

The purpose of present research work is to develop gastro retentive formulation for Moxifloxacin using various release retardants. Moxifloxacin, that is a novel synthetic fluoro quinolone, is an iantibacterial agent. Floating tablets of Moxifloxacin. HCl were prepared using variable amounts of HPMCK4M, HPMCK15M and HPMCK100M with effervescent mixtures by direct compression technique. Totally 9 formulations were designed, prepared and are evaluated for various pharmacopoeial tests like uniformity of weight, thickness,Hardness, friability, floating lag time, Total floating time. Drug release profiles of formulation trails subjected to kinetic modeling. Parameters like correlation coefficient(r), slope (b), intercept (a) were determined. The results reveal that floating lag time decreases with decreased viscosity of polymer composites. According to SUPAC guidelines formulation (F4) containing 12.5% HPMCK15M was found to be most identical formulation (similarity factor f2= 70.997, dissimilarity factor f1= 6.007 to marketed product (AVELOX). Trail F4 drug release found to be first order kinetics, Non-Fickian Diffusion Anomalous Transport. (n= 1.065).

Keywords:
  • Moxifloxacin
  • HCl
  • Gastroretentive
  • Floating Lag Time
  • HPMCK15M
  • Anomalous transport
  • First order kinetics
  • IJPS_Volume 16_Issue 1_Pages 49-60

How to Cite

Gunda, R. K. ., & Vijayalakshmi, A. . (2020). Formulation Development and Evaluation of Gastro Retentive Floating Drug Delivery System for Novel Fluoroquinolone using Natural and Semisynthetic Polymers: Formulation development and evaluation of Moxifloxacin. HCl gastroretentive floating tablets. Iranian Journal of Pharmaceutical Sciences, 16(1), 49–60. https://doi.org/10.22037/ijps.v16.40446
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[1] Praveen N, Mahant S, Sharma D. Floating systems: A novel approach towards gastro retentive drug delivery systems. Int. J. Pharm. Pharm. Sci.(2010) 2 (2): 3-15.
[2] Sonia D, Singh TG, Kumar AR, Sood S, Arora.Gastro retentive: controlled release drug delivery system. Asian .J. Pharm .Clin. Res. (2011) 4 (1): 5-13.
[3] Satyajit Panda, Neeraja Sukanya Sailada, Bandaru Devi, Snigdha Pattnaik, Laxmidhar Maharana. Design of floating drug delivery systems: an update on polymeric advancements with special reference from
natural origin. Int. J. Pharm. Sci. Rev. Res. (2016) 39 (1) Article No. 26: 125-32.
[4] Hirtz J. The GIT absorption of drugs in man: a review of current concepts and methods of investigation. Br. J. Clin. Pharmacol. (1985) 19: 77-83.
[5] Shwetha Arora, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A Review. AAPS.Pharm. Sci. Tech. (2005) 6 (3): E372-90.
[6] Jain SK, Agarwal GP, Jain NK. Floating microspheres as drug delivery system: Newer Approaches, evaluation of porous carrier-based floating or list at microspheres for gastric delivery. AAPS. Pharm. Sci. Tech. (2006) 7 (4) article 90:E1-E9.
[7] Reddy LH, Murthy RS. Floating dosage system in drug delivery. Crit. Rev. Ther. Drug carrier. Syst.(2002)19 (6): 553- 85.
[8] PN Murthy, Anjan K. Mahapatra, Tapan Kumar Nayak and Diptanu Dey. Formulation, characterization and drug release kinetics of floating drug delivery systems. J. Chem. Pharm. Res. (2015) 7(6): 781-92.
[9] Raghavendra Kumar Gunda, A.Vijayalakshmi.Formulation Development and Evaluation of Gastro Retentive Drug Delivery Systems- A Review. J.Pharm. Res. (2017)11 (2): 167-78.
[10] K.Varun Kumar, Ajaykumar B. Formulation and evaluation of rapid disintegration tablets of Moxifloxacin HCl. Der. Pharm. Lett. (2013) 5(1):238-50.
[11] Ramji Anil Kumar Arza and B. Vijaya Kumar.Development and evaluation of gastroretentive floating matrix tablets of Moxifloxacin HCl. Der.Pharm. Lett. (2016) 8 (10): 140-9.
[12] Jainish Patel, Aakash Patel and Zankhana Sheth.Formulation and Optimization of Floating Effervescent Tablet of Roxatidine Acetate. Int. J.Pharm. Archive. (2014) 3 (5): 447-52.
[13] SR Dawange, SS Khadabadi, SS Saboo.Formulation and Evaluation of Floating Tablets of Verapamil Hydrochloride by using Gastroretentive Technology. Int. J. Pharm. Sci. Rev. Res. (2015) 34(1), 263-269.
[14] Raghavendra Kumar Gunda. Formulation development and evaluation of Rosiglitazone Maleate Sustained release tablets using 32 factorial design. Int.J. Pharm. Tech. Res. (2015) 8(4):713-24.
[15] Raghavendra Kumar Gunda, Naga Suresh Kumar Jujjuru. (2017). Formulation development and evaluation of Moxifloxacin.HCl fast dissolving tablets. Pharm. Meth. (2017) 8 (2): 160-7.
[16] Rosa M, Zia H, Rhodes CT. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int.J.Pharmaceutics.(1994) 105 (1): 65-70.
[17] Dave BS, Amin AF, Patel MM. Gastroretentive drug delivery system of ranitidine hydrochloride:Formulation and in vitro evaluation. AAPS. Pharm.Sci. Tech. (2004) 5 (2): e34: 1-6.
[18] Raghavendra Kumar Gunda, J.N.Suresh Kumar.Design, Formulation and Evaluation of Atenolol Gastro Retentive Floating Tablets. Asian. J. Pharm.(2015) 9 (4): S34- S42.
[19] Higuchi. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci.(1963) 51: 1145-9.
[20] Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta.Helv. (1985) 60: 110-1.
[21] Notari RE. Biopharmaceutics and clinical pharmacokinetics. 4th ed. New York: Marcel Dekker Inc, (1987): 6-21.
[22] Dortunc B, Gunal N. Release of acetazolamide from swellable HPMC matrix tablets. Dru. Dev. Ind.Pharm. (1997) 23: 1245-9.
[23] Gunda RK, Kumar JNS, Babu CA and Anjaneyulu MV. Formulation Development and Evaluation of Lamotrigine Sustained Release Tablets Using 32 Factorial Design. Int. J. Pharm. Sci. Res.(2015) 6 (4): 1746-52.
  • Abstract Viewed: 506 times
  • IJPS_Volume 16_Issue 1_Pages 49-60 Downloaded: 483 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus